About THC activation and effects
In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they plan to reclassify cannabis as a Program III drug. This rescheduling will identify that cannabis has respectable clinical uses and can help open the doorway to investigation on other potential therapy uses.Hallucinogens in small doses may also resemble cannabis intoxicatio